Biotech StocksStock News Stock Update (NASDAQ:ICPT): Intercept Pharmaceuticals Inc Announces FDA Grants Ocaliva™ (Obeticholic Acid) Accelerated Approval for for the Treatment of Patients with PBC Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, today announced … Corey Williams, May 31, 2016
Analyst InsightsBiotech Stocks Needham Weighs In on Intercept Pharmaceuticals Inc (ICPT) Following Meeting with Mangemant Needham & Company analyst Alan Carr weighs in with a few insights on Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after hosting a meeting with Doug Dieterich, MD and Alyson Harty, … Oz Talmor, May 19, 2016
Bloggers CornerHealthcareTechnology Zacks Updates: Facebook Inc (FB), Intercept Pharmaceuticals Inc (ICPT), Relypsa Inc (RLYP) Facebook Inc Facebook Inc (NASDAQ:FB) has added some new features to its Facebook Live to give people “more ways to discover, share, and interact … Zacks Equity Research, April 8, 2016
Biotech StocksInsightsMost Popular This Analyst Remains Bearish on Intercept Pharmaceuticals Inc (ICPT) Despite Positive Ad Comm Vote Merrill Lynch’s healthcare analyst Ying Huang weighed in on Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after the FDA advisory committee unanimously recommended approval of the company’s liver drug. The … Jason Cohen, April 8, 2016
Biotech StocksInsightsMost PopularTop Stories Analysts Weigh In On Three Biotech Stocks: Relypsa Inc (RLYP), Juno Therapeutics Inc (JUNO), Intercept Pharmaceuticals Inc (ICPT) The iShares Nasdaq Biotechnology ETF (IBB) is poised to open higher on Friday, boosted by Federal Reserve Chair Janet Yellen’s positive comments on the economy. Among … Jason Cohen, April 8, 2016
Biotech StocksInsights Relypsa Inc (RLYP) and Intercept Pharmaceuticals Inc (ICPT) Attract Analysts In Light of Potential Acquisition and Favorable FDA’s Panel Outcome Healthcare analysts weigh in on drug makers Relypsa Inc (NASDAQ:RLYP) and Intercept Pharmaceuticals Inc (NASDAQ:ICPT), as one explores potential sale and the other gets closer to FDA … Jason Cohen, April 8, 2016
Biotech StocksStock News Stock Update (NASDAQ:ICPT): FDA Advisory Committee Supports Intercept Pharmaceuticals Inc’s Ocaliva for the Treatment of Primary Biliary Cholangitis Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, … Corey Williams, April 7, 2016
Analyst InsightsBiotech Stocks Biotech Analysts See Catalysts for Intercept Pharmaceuticals Inc (ICPT) and bluebird bio Inc (BLUE) Leerink and Wedbush analysts highlight potential catalysts for Intercept Pharmaceuticals Inc (NASDAQ:ICPT) and bluebird bio Inc (NASDAQ:BLUE). One analyst believes that better than expected briefing … Shira Gonen, April 6, 2016
Biotech StocksInsights Analysts Weigh In on Two Raising Healthcare Stocks: Valeant Pharmaceuticals Intl Inc (VRX) and Intercept Pharmaceuticals Inc (ICPT) Valeant Pharmaceuticals Intl Inc Shares of Valeant Pharmaceuticals are rising nearly 10% today, after the company announced that an Ad Hoc Committee has completed its review … Jason Cohen, April 5, 2016
Biotech StocksConsumer StocksStock NewsTechnology Stocks Tuesday Morning’s Market Insights: Twitter Inc (TWTR), Tesla Motors Inc (TSLA), Allergan plc Ordinary Shares (AGN), Intercept Pharmaceuticals Inc (ICPT) Twitter Inc (NYSE:TWTR) is up over 2% in pre-market trading after Bloomberg reported that it will broadcast NFL games online on Thursday nights. … Shira Gonen, April 5, 2016
